New Report: Quality Adjusted Life Years (QALY) Methodology Discriminates Against Older Americans, Threatens to Deny Seniors Access to Life-Saving Care

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Pioneer Institute Asserts that with Older Americans More Vulnerable during the COVID-19 Pandemic, All Health Plans Should Avoid Using the QALY Methodology When Assessing the Value of Care for Older Patients

Boston, MA (April 2, 2020) – Today, Pioneer Institute released a new report, Quality Adjusted Life Years (QALY): The Threat to Older Americans, which examines how the QALY methodology to determine drug treatment value threatens to discriminate against older adults by placing a lower value on treatments that would extend the life of or improve quality of life for older patients.  This clear bias against providing access to therapies to seniors comes at a critical and especially vulnerable time for older Americans given the coronavirus disease (COVID-19).  Authored by Pioneer Institute Visiting Fellow in Life Sciences, Dr. William Smith, the report concludes that the QALY methodology, utilized most notably by the Institute for Clinical and Economic Review (ICER), has the potential to deny seniors’ access to high-quality, life-saving treatments.

QALYs rate medical treatments according to their ability to extend life and to improve the quality of life. Pioneer Institute’s report explains how the QALY method of assessing the value of medicines is inherently discriminatory and ageist, as it will consistently rate treatments for older Americans as less cost-effective than for younger people. The report explains:

“Treatments that provide more ‘life years’ will be rated as ‘more effective’ under QALY, which superficially sounds commonsensical unless you realize that this standard will, by definition, be used to argue that drugs for senior citizens with shorter life expectancies will be rated lower than drugs for younger people.” (Pg. 1)

Pioneer Institute’s report explores how the use of the QALY methodology would specifically affect those receiving palliative care. While palliative care treatments may significantly improve the quality of life for patients with a serious or life-limiting condition, they often do not extend it. The report illustrates how the QALY methodology contains inherent bias when applied to palliative care:

“Palliative care highlights the problem of using the QALY methodology generally: not every decision made in healthcare should be justified solely based on cost-effectiveness. Human beings make value judgments about how to care for their fellow human beings…These formulas themselves are based upon certain value judgments that human life is less valuable than many Americans think.” (Pg. 3)

Pioneer Institute’s report warns that federal policy proposals that consider the use of QALYs to make treatment access decisions, such as “Medicare for All,” could have disastrous consequences for American seniors. The report concludes:

“Senior citizens who become enrolled in a Medicare for All plan and are then denied valuable treatments based upon a QALY cost-effectiveness review might not share ICER’s view on the value of QALYs. Not only is ICER’s modeling of the value of longevity flawed, they also de-value treatments such as palliative care that are extremely important to older Americans and their families but may not increase longevity.” (Pg. 3)

Read a one-page fact sheet on the report.

###

About the Author

William S. Smith is Visiting Fellow in Life Sciences at Pioneer Institute.  He has 25 years of experience in government and in corporate roles, including as vice president of public affairs and policy at Pfizer, and as a consultant to major pharmaceutical, biotechnology and medical device companies. He held senior staff positions for the Republican House leadership on Capitol Hill, the White House, and in the Massachusetts Governor’s office. He is affiliated as research fellow and managing director with the Center for the Study of Statesmanship at The Catholic University of America (CUA), where he earned his PhD.

About Pioneer Institute

Pioneer Institute is an independent, non-partisan, privately funded research organization that seeks to improve the quality of life in Massachusetts through civic discourse and intellectually rigorous, data-driven public policy solutions based on free market principles, individual liberty and responsibility, and the ideal of effective, limited and accountable government.

Get Updates On Our Life Sciences Work!

Related Posts:

Prof. Raymond Arsenault on the 60th Anniversary of the Freedom Rides & Civil Rights

This week on “The Learning Curve," co-hosts Gerard Robinson and Cara Candal talk with Raymond Arsenault, the John Hope Franklin Professor of Southern History at the University of South Florida, and author of several acclaimed and prize-winning books on civil rights, including Freedom Riders: 1961 and the Struggle for Racial Justice. He shares how he became interested in researching, writing, and teaching about the Civil Rights Movement.

Study: After Years of Steady Increases, Homeschooling Enrollment Rose Dramatically During COVID

After steadily increasing for years, the number of parents choosing to homeschool their children skyrocketed during the pandemic, and policy makers should do more to acknowledge homeschooling as a viable option, according to a new study published by Pioneer Institute.

ASU’s Julie Young, Virtual Schooling Pioneer, on Digital Learning during COVID-19

This week on “The Learning Curve," co-host Cara Candal talks with Julie Young, ASU Vice President of Education Outreach and Student Services, and Managing Director of ASU Prep Academy and ASU Prep Digital. They discuss the implications of COVID-19’s disruption of American K-12 education and the future of digital learning.

UChicago’s Dr. Leon Kass on Genesis, Exodus, & Reading Great Books

This week on “The Learning Curve," guest co-host Jason Bedrick and co-host Gerard Robinson talk with Dr. Leon Kass, MD, the Addie Clark Harding Professor Emeritus in the Committee on Social Thought and the College at the University of Chicago. Dr. Kass describes the important pieces of wisdom and humanity people today can still learn from reading the Book of Genesis, the topic of his 2003 work, The Beginning of Wisdom.

“America Today is on Bended Knee” – 20th Anniversary of 9/11 – 20 Resources for Parents & Students

The heroic stories of 9/11 are part of our national consciousness and memory. It’s the duty and obligation of the living and those who survived to pass along this history to the next generation. As Americans mourn the events of 20 years ago, while in the midst of another national crisis during COVID-19, let’s recommit ourselves to teaching students and the younger generation about seminal events like 9/11 that still shape our world today. To support this effort, we’re offering a variety of resources to help parents, teachers, and high school students.

NYT Best Seller Dr. Kate Clifford Larson on Fannie Lou Hamer & the Mississippi Civil Rights Movement

This week on “The Learning Curve," co-hosts Cara Candal and Gerard Robinson talk with Dr. Kate Clifford Larson, a New York Times best-selling biographer of Harriet Tubman and Fannie Lou Hamer. Kate shares why she has written about these historical African-American figures, and how she thinks parents, teachers, and schools can draw on their lives to talk about race.

Valhalla Foundation’s Nancy Poon Lue on STEM Access & Equity

This week on “The Learning Curve," host Gerard Robinson talks with Nancy Poon Lue, incoming Senior Director at the Valhalla Foundation, where she will be leading their K-12 math funding initiatives. Nancy shares her recent work with the EF+Math Program, some of the challenges America has faced in ensuring students have a strong grounding in math and science, and the kinds of results she aims to achieve for kids in all ZIP codes. 

Untangling Variants & Outbreaks: Can Vaccines & Natural Immunity Outrun Delta?

Hubwonk host Joe Selvaggi talks with author, surgeon, and public health expert Dr. Marty Makary about the COVID-19 Delta Variant, the durability of natural and vaccinated immunity, the benefits of booster shots, and the health risks for children as we move into the fall.